Abiopharma

🔍 DOLAN JAMES LAWRENCE (Executive)

Company: Madison Square Garden Entertainment Corp. (MSGE)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 53,657 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-26 | Code: A | Expires: 2029-09-15 | equity_swap_involved: false | shares_owned_after: 53,657.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 99,565 shares of Performance Restricted Stock Units (Derivative)
  Date: 2026-08-26 | Code: A | Expires: 2026-09-15 | equity_swap_involved: false | shares_owned_after: 99,565.00 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: Each restricted stock unit ("RSU") is granted under the Madison Square Garden Entertainment Corp. ("MSGE") 2023 Employee Stock Plan (the "Employee Stock Plan) and represents a right to receive one share of Class A Common Stock or the cash equivalent thereof.
• F2: The RSUs are scheduled to vest and settle in three equal installments on September 15, 2027, September 15, 2028 and September 15, 2029.
• F3: Each performance restricted stock unit ("PSU") was granted on September 1, 2023 under the Employee Stock Plan and represents a right to receive one share of MSGE Class A Common Stock or the cash equivalent thereof. The performance conditions were satisfied on August 26, 2026. The PSUs are scheduled to vest and settle on September 15, 2026.